The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has received three important distinctions for the quality of its cancer registry data.
Dr. Graham Roger Serjeant, a world-renowned researcher and authority on sickle cell disease management and care, will visit the University of Miami Miller School of Medicine on Friday, Oct. 20, to tour the Pediatric Sickle Cell Unit at UM/Jackson Memorial Hospital and make a presentation about best practices for medical professionals caring for patients with sickle cell anemia.
A six-person pediatric team from the University of Miami Miller School of Medicine traveled to Puerto Rico on October 10 to provide firsthand support for their colleagues in San Juan and two rural impoverished communities still devastated by Hurricane Maria.
Big data and artificial intelligence (AI) are emerging as powerful tools for improving patient care, advancing medical research and promoting public health. But the use of large datasets of electronic health records, along with other patient information, raises a host of ethical, legal and social issues, University of Miami President Julio Frenk told a global conference hosted by UM and the World Health Organization.
The University of Miami Miller School of Medicine’s Department of Otolaryngology-Head & Neck Surgery was recently recognized by two prestigious ratings organizations. The otolaryngology program at University of Miami Hospital was ranked No. 35 in the U.S. News & World Report Best Hospitals survey, and the department was ranked No. 14 for NIH-funded research as compiled by the Blue Ridge Institute for Medical Research.
Despite prevention efforts, researchers at the University of Miami Miller School of Medicine have found a significant increase over a 10-year period in the percentage of people with stroke who have high blood pressure, diabetes, smoking and other risk factors for stroke. The study is published in the October 11 online issue of Neurology®, the medical journal of the American Academy of Neurology.
More and more often in this era of big data, it’s not a lack of information that’s the issue. Instead, it can be sorting through a tsunami of data to find what’s most relevant and meaningful to drive medical research forward. Now a $1.4 million grant from the National Institute of Health will boost efforts of a team of researchers at the University of Miami Miller School of Medicine.
Hansel Tookes, M.D., MPH, assistant professor of medicine in the Division of Infectious Diseases at the University of Miami Miller School of Medicine, has been named one of 11 national “Upstanders” by Starbucks and is featured in a video that was screened in New York on Oct. 9. The video tells the story of Tookes’ multi-year campaign to save lives through the Infectious Disease Elimination Act (IDEA) in Florida.
A University of Miami Miller School of Medicine research team has identified an innovative epigenetic strategy using a single molecule to turn off multiple genes that drive Alzheimer’s disease. The researchers demonstrated that an epigenetic molecule called M344 penetrates the brain, targets the buildup of beta-amyloid peptides associated with Alzheimer’s disease, increases neuroprotective genes and increases memory.
The Miami Dolphins announced the Dolphins Cancer Challenge VII (DCC VII) raised $6,000,157 for innovative cancer research at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, bringing the event’s seven-year total to more than $22.5M.